Doctor profile · Federal record
Dr. Kyle Eash, M.D. PH.D.
Dermatology Physician (CMS: Dermatology) · Wentzville, MO
- NPI 1790072395
- Accepts Medicare
- MIPS 83.3 / 100 · 2023
- 15 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1603 Wentzville Pkwy Ste 123
Wentzville, MO 633853826
(636) 695-0300
fax (636) 695-0301 - Additional location
-
915 N Grand Blvd
Saint Louis, MO 631061621
(314) 652-4100 - Mailing address
-
1008 S Spring Ave Fl 3
Saint Louis, MO 631102520
Credentials & registration
- NPI registered
- July 2011 — 15 yrs on file
- Profile last updated
- May 27, 2024
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Missouri #2015018653
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1790072395. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,131
Distinct HCPCS
10
Medicare allowed
$340,114
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 2,721 | 478 | $6 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 794 | 564 | $123 | |
17000 |
Destruction of precancer skin growth, 1 growth | 728 | 595 | $50 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 525 | 469 | $88 | |
11102 |
Biopsy of related skin growth, first growth | 402 | 357 | $89 | |
17110 |
Destruction of skin growth, 1-14 growths | 318 | 287 | $108 | |
11103 |
Biopsy of related skin growth, each additional growth | 215 | 142 | $49 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 208 | 164 | $164 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 48 | 48 | $162 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 42 | 42 | $109 |
In context: peer comparison
Among 4 peers in Wentzville Dermatology Physician, average services per provider: 211. This provider delivers 29× the peer median.Open Payments
Industry payments received
All-time total
$1,738
Transactions
23
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Dermavant Sciences, INC. | 4 | $492.54 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $235.44 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 2 | $231.77 | |
| Galderma Laboratories, L.P. | 2 | $217.01 | |
| Janssen Scientific Affairs, LLC | 3 | $136.05 | |
| Organogenesis INC. | 1 | $123.88 | |
| Regeneron Healthcare Solutions, INC. | 1 | $116.96 | |
| Amgen INC. | 1 | $111.62 | |
| Novartis Pharmaceuticals Corporation | 2 | $48.57 | |
| Janssen Biotech, INC. | 2 | $23.67 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,499
Patients
911
Total drug cost
$32,757
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 369 | 184 | $7,271 |
| Triamcinolone Acetonide | Generic | 270 | 201 | $1,895 |
| Doxycycline Hyclate | Generic | 124 | 47 | $3,286 |
| Hydrocortisone | Generic | 123 | 89 | $936 |
| Clobetasol Propionate | Generic | 108 | 66 | $6,442 |
| Mupirocin | Generic | 90 | 77 | $781 |
| Metronidazole | Generic | 84 | 55 | $4,770 |
| Cephalexin | Generic | 72 | 44 | $884 |
| Fluocinonide | Generic | 57 | 39 | $2,332 |
| Prednisone | Generic | 47 | 17 | $213 |
Frequently asked questions
What is Dr. Kyle Eash's medical specialty?
Dr. Kyle Eash practices Dermatology Physician in Wentzville, MO.
Where does Dr. Kyle Eash practice?
Dr. Kyle Eash practices at 1603 Wentzville Pkwy Ste 123, Wentzville, MO 633853826. Office phone: 6366950300.
What is Dr. Kyle Eash's NPI?
Dr. Kyle Eash's National Provider Identifier (NPI) is 1790072395, issued by NPPES.
Does Dr. Kyle Eash accept Medicare assignment?
Yes. Dr. Kyle Eash accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kyle Eash commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.